E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 11/28/2006 in the Prospect News Structured Products Daily.

New Issue: HSBC USA sells $744,000 of 8.5% notes linked to St. Jude

By Laura Lutz

Washington, Nov. 28 - HSBC USA Inc. priced a $744,000 issue of 8.5% reverse convertible notes due Nov. 30, 2007 linked to St. Jude Medical, Inc. stock, according to a 424B2 filing with the Securities and Exchange Commission.

The payout at maturity will be par in cash unless St. Jude stock falls below the barrier price of $29.52 during the life of the notes and finishes below its initial price, in which case payout will be a number of St. Jude shares equal to $1,000 divided by the initial share price.

Issuer:HSBC USA Inc.
Issue:Reverse convertible notes
Underlying stock:St. Jude Medical, Inc.
Amount:$744,000
Maturity:Nov. 30, 2007
Coupon:8.5%, paid quarterly
Price:Par
Payout at maturity:Par in cash unless St. Jude stock falls below $29.52 during the life of the notes and finishes below its initial price, in which case 27.10027 shares of St. Jude stock
Initial share price:$36.90
Barrier price:$29.52, 80% of initial share price
Pricing date:Nov. 27
Settlement date:Nov. 30
Agent:HSBC Securities (USA) Inc.
Agent fee:2.25%

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.